全文获取类型
收费全文 | 22898篇 |
免费 | 1615篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 384篇 |
儿科学 | 684篇 |
妇产科学 | 413篇 |
基础医学 | 3234篇 |
口腔科学 | 356篇 |
临床医学 | 2198篇 |
内科学 | 4681篇 |
皮肤病学 | 891篇 |
神经病学 | 2351篇 |
特种医学 | 865篇 |
外国民族医学 | 2篇 |
外科学 | 3471篇 |
综合类 | 214篇 |
一般理论 | 5篇 |
预防医学 | 1594篇 |
眼科学 | 367篇 |
药学 | 1454篇 |
中国医学 | 34篇 |
肿瘤学 | 1360篇 |
出版年
2023年 | 114篇 |
2021年 | 320篇 |
2020年 | 212篇 |
2019年 | 280篇 |
2018年 | 624篇 |
2017年 | 428篇 |
2016年 | 541篇 |
2015年 | 593篇 |
2014年 | 585篇 |
2013年 | 930篇 |
2012年 | 1551篇 |
2011年 | 1588篇 |
2010年 | 763篇 |
2009年 | 623篇 |
2008年 | 1222篇 |
2007年 | 1333篇 |
2006年 | 1277篇 |
2005年 | 1202篇 |
2004年 | 1144篇 |
2003年 | 1044篇 |
2002年 | 1015篇 |
2001年 | 581篇 |
2000年 | 561篇 |
1999年 | 551篇 |
1998年 | 154篇 |
1997年 | 120篇 |
1996年 | 100篇 |
1995年 | 117篇 |
1994年 | 121篇 |
1993年 | 96篇 |
1992年 | 252篇 |
1991年 | 292篇 |
1990年 | 237篇 |
1989年 | 236篇 |
1988年 | 202篇 |
1987年 | 213篇 |
1986年 | 200篇 |
1985年 | 211篇 |
1984年 | 138篇 |
1983年 | 141篇 |
1981年 | 95篇 |
1979年 | 140篇 |
1978年 | 101篇 |
1977年 | 92篇 |
1975年 | 117篇 |
1974年 | 122篇 |
1973年 | 101篇 |
1972年 | 111篇 |
1971年 | 99篇 |
1968年 | 92篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Lillyblad Matthew P. Qadri Ghaziuddin A. Weise Brynn E. Smith Claire S. St. Hill Catherine Tierney David M. Melamed Roman R. 《Journal of thrombosis and thrombolysis》2022,54(4):605-615
Journal of Thrombosis and Thrombolysis - Alteplase treatment can cause a systemic coagulopathy although the incidence and contributory factors are unknown in pulmonary embolism (PE). Fixed-dosing... 相似文献
3.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
4.
5.
6.
Yong Zhao Danielle Garrity Molly Graves Jeanne Linden Patricia St. Pierre Paula Ducharme Mindy Greene Michelle Vauthrin Robert Weinstein 《Journal of clinical apheresis》2019,34(6):656-660
We sought to optimize direct intravenous infusion of calcium gluconate (CaGlu) for maintaining plasma ionized calcium concentration ([Ca2+]) and preventing hypocalcemic reactions during 34 consecutive 1-volume therapeutic plasma exchanges (TPEs) in eight patients. CaGlu, 2 g in 50 mL of 0.9% NaCl, was prepared by our hospital pharmacy and infused at either 1.0 or 1.6 g/h during alternate TPE. Plasma [Ca2+] was monitored at intervals of 20 to 30 minutes. At 1 g/h of CaGlu, plasma [Ca2+] fell by 8.35% after 40 to 50 minutes and then plateaued. At 1.6 g/h of CaGlu, plasma [Ca2+] fell by 6% after 20 to 30 minutes and then plateaued. The difference at 40 to 50 minutes was significant (P = .015). Hypocalcemic reactions were noted in three patients during 5 of 17 TPE at 1.0 g/h (all after 40 to 60 minutes) but 0 of 17 TPE at 1.6 g/h (P = .044). CaGlu at 1.6 g/h stabilized plasma [Ca2+] and appears to prevent hypocalcemic reactions during TPE. 相似文献
7.
Li Dong Mari Nygård Nathalie C. Støer Ole Klungsøyr Bo T. Hansen 《International journal of cancer. Journal international du cancer》2023,153(2):399-406
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program. We performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016. We estimated the incidence rate ratio (IRR) and 95% confidence intervals (CI) for vaccination vs no vaccination by Poisson regression stratified by age at vaccination <20 years and ≥20 years. The cohort consisted of 832 732 women, of which 46 381 (5.6%) received at least one dose of HPV vaccine by the end of 2016. The incidence rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased with age regardless of vaccination status and was highest at age 25 to 29, at 637/100 000 among unvaccinated women, 487/100 000 among women vaccinated before age 20 and 831/100 000 among women vaccinated at age 20 or older. The adjusted IRR of CIN2+ between vaccinated and unvaccinated women was 0.62 (95% CI: 0.46-0.84) for women vaccinated below age 20, and 1.22 (95% CI: 1.03-1.43) for women vaccinated at age 20 or older. These findings indicate that HPV vaccination among women too old to be eligible for routine HPV vaccination is effective among women who are vaccinated below age 20 but may not have the desired impact among women who are vaccinated at age 20 or older. 相似文献
8.
Eric Liozon Simon Parreau Matthieu Filloux Stéphanie Dumonteil Guillaume Gondran Holy Bezanahary K.H. Ly Anne Laure Fauchais 《Autoimmunity reviews》2021,20(2):102732
IntroductionGiant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory rheumatic diseases common in people over the age of 50 years. Seasonal influenza vaccination (IV) is strongly recommended in this population, among whom it is considered to be effective and well tolerated. IV-induced GCA or PMR are thought to be exceptional.Patients and methodsWe retrieved all post-IV cases from an inception cohort of patients with newly diagnosed GCA. We also included two patients with post-IV PMR and reviewed all published reports of post-IV GCA or PMR, with selection of cases demonstrating disease onset within 1 month following IV. We compared the results of HLA-DRB1 typing, performed in seven patients with post-IV GCA or PMR, with those of 11 GCA patients with familial aggregation and 16 randomly selected GCA patients without a reported trigger.ResultsOf 358 GCA recruited since 2002, 10 (2.8%) qualified for post-IV GCA, of whom two also showed familial aggregation. Thirty-two patients (19 with GCA and 13 with PMR) including our patients were reviewed; their mean age was 71.8 ± 7.4 years and the M/F ratio was 0.8. Six patients (19%) had a history of PMR. Patients with post-IV GCA/PMR had the DRB1*13:01 haplotype more frequently compared to those with familial GCA (5/7 vs. 2/11, p = 0.048) or with GCA without a known trigger (3/16, p = 0.026). Post-IV PMR generally appeared self-limited, whereas post-IV GCA often displayed a more protracted course (chronic relapsing disease in one-third of the patients).ConclusionPost-IV onset of GCA/PMR is not an exceptional occurrence and may be part of the spectrum of the autoimmune syndrome induced by adjuvants (ASIA). IV can trigger GCA or PMR, especially in persons at higher spontaneous risk, such as those with a personal or familial history of GCA/PMR. Whether the presence of the DRB1*13:01 allele further increases the risk of post-IV GCA/PMR through a stronger vaccine-induced immune reaction deserves further investigation. Unlike PMR, GCA can be a serious complication of IV. 相似文献
9.
10.
The coronavirus disease 2019 (COVID-19) pandemic is challenging healthcare systems worldwide, none more so than critical and intensive care settings. Significant attention has been paid to the capacity of Australian intensive care unit (ICUs) to respond to a COVID-19 surge, particularly in relation to beds, ventilators, staffing, personal protective equipment, and unparalleled increase in deaths in ICUs associated with COVID-19 seen internationally. While death is not uncommon in critical care, the international experience demonstrates that restrictions to family presence at the end of life result in significant distress for families and clinicians. As a result, the Australian College of Critical Care Nurses and the Australasian College for Infection Prevention and Control supported the development of a position statement to provide critical care nurses with specific guidance and recommendations for practice for this emerging priority area. Where possible, position statements are founded on high-quality evidence. However, the short time period since the first recognition of a cluster of pneumonia-like cases in China in January, 2020, meant that an integrative approach was required to expedite timely development of this position statement in preparation for a COVID-19 surge in Australia. This position statement is intended to provide practical guidance to critical care nurses in facilitating next-of-kin presence for patients dying from COVID-19 in the ICU. 相似文献